Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study

By afschroeder • October 30, 2026

Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung K, Calais J, Eggener SE, Brisbane W, Reiter RE, Raman S, Weiner AB. Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study. J Nucl Med. 2026 Oct 29:jnumed.126.273367. doi: 10.2967/jnumed.126.273367. Epub ahead of print. PMID: 42957199.

Tags: Cardiology/Epi, DOM STAT, focal therapy, General Internal Medicine, multiparametric MRI, prostate cancer, PSMA PET/CT, Publications, whole-mount histopathology

Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR

Pogosyan A, Liu Y, Patel JA, Mahmoudi M, Xu H, Finn JP, Nguyen KL. Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR. Curr[...]

A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention

Song MR, Ziaeian B. A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention. JACC Heart Fail. 2026 Oct 28:103489. doi: 10.1016/j.jchf.2026.103489. Epub[...]

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

Peluso MJ, Ryder D, Dalhuisen T, Chu DHT, Williams MC, Rodriguez AE, LaFranchi BH, Vinden J, Fehrman EA, Huang B, Hoh R, Asare KA, Bellon[...]